The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The price of Alignment Healthcare Inc (NASDAQ: ALHC) closed at $15.33 in the last session, down -2.23% from day before closing price of $15.68. In other words, the price has decreased by -$2.23 from its previous closing price. On the day, 4.0 million shares were traded.
Ratios:
We take a closer look at ALHC’s different ratios to gain a better understanding of the stock. In the meantime, Its Debt-to-Equity ratio is 3.05 whereas as Long-Term Debt/Eq ratio is at 3.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stephens on December 03, 2024, Upgraded its rating to Overweight and sets its target price to $17 from $13 previously.
BofA Securities Upgraded its Neutral to Buy on May 30, 2024, whereas the target price for the stock was revised from $7.75 to $11.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 19 ’25 when General Atlantic (ALN HLTH), L sold 17,000,000 shares for $15.28 per share. The transaction valued at 259,760,000 led to the insider holds 44,302,175 shares of the business.
GENERAL ATLANTIC, L.P. sold 17,000,000 shares of ALHC for $259,760,000 on May 19 ’25. The Director now owns 44,302,175 shares after completing the transaction at $15.28 per share. On May 19 ’25, another insider, General Atlantic (ALN HLTH), L, who serves as the Affliliate of the company, bought 17,000,000 shares for $16.24 each.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 1.01 while its Price-to-Book (P/B) ratio in mrq is 28.02.
Stock Price History:
Over the past 52 weeks, ALHC has reached a high of $21.06, while it has fallen to a 52-week low of $6.92. The 50-Day Moving Average of the stock is -10.55%, while the 200-Day Moving Average is calculated to be 15.57%.
Shares Statistics:
A total of 197.67M shares are outstanding, with a floating share count of 113.33M. Insiders hold about 42.72% of the company’s shares, while institutions hold 59.05% stake in the company.
Earnings Estimates
Its stock is currently analyzed by 5.0 different market analysts. The consensus estimate for the next quarter is -$0.02, with high estimates of $0.01 and low estimates of -$0.07.
Analysts are recommending an EPS of between $0.03 and -$0.03 for the fiscal current year, implying an average EPS of -$0.0. EPS for the following year is $0.16, with 4.0 analysts recommending between $0.19 and $0.08.
Revenue Estimates
According to 10 analysts, the current quarter’s revenue is expected to be $982.11M. It ranges from a high estimate of $1.18B to a low estimate of $951.89M. As of the current estimate, Alignment Healthcare Inc’s year-ago sales were $681.29MFor the next quarter, 10 analysts are estimating revenue of $955.64M. There is a high estimate of $966.5M for the next quarter, whereas the lowest estimate is $947.9M.
A total of 9 analysts have provided revenue estimates for ALHC’s current fiscal year. The highest revenue estimate was $3.82B, while the lowest revenue estimate was $3.75B, resulting in an average revenue estimate of $3.79B. In the same quarter a year ago, actual revenue was $2.7BBased on 10 analysts’ estimates, the company’s revenue will be $4.81B in the next fiscal year. The high estimate is $5.01B and the low estimate is $4.63B.
